Source: Eur Respir J, 57 (3) 2004008; 10.1183/13993003.04008-2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Yunus Çolak. Cardiac disease from accelerated FEV₁ decline and acute exacerbations: time to rethink comorbidities in COPD. Eur Respir J, 57 (3) 2004008; 10.1183/13993003.04008-2020

Member's Comments

No comment yet.

Related content which might interest you: FEV1 decline in patients with chronic obstructive pulmonary disease: Which treatment option is better for slowing of decline? Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Cognitive dysfunction is greater in patients hospitalised with COPD exacerbations than with worsening heart failure Source: International Congress 2014 – Markers Year: 2014 Acute exacerbations of COPD: The influence of comorbidities and chronic medication on mortality and exacerbation rate Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 C-reactive protein at discharge, diabetes mellitus and ≥1 prior hospitalization predict early readmission in patients with acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD Source: ERJ Open Res, 7 (1) 00718-2020; 10.1183/23120541.00718-2020 Year: 2021 Acute exacerbations of chronic obstructive pulmonary disease: Is it acute exacerbations of chronic cardiopulmonary disease? Source: International Congress 2014 – Comorbidities Year: 2014 Cognitive decline following an acute exacerbation of COPD (AECOPD) Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 Early readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is associated with high mortality Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Changes in cognitive status during acute exacerbation of COPD Source: International Congress 2015 – Rehabilitation, exercise, hospitalisation and COPD Year: 2015 COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis Source: International Congress 2016 – Dealing with the complexity of critically-ill patients Year: 2016 Are re-admissions with acute exacerbation of chronic obstructive pulmonary disease coded correctly? Source: International Congress 2014 – COPD exacerbations Year: 2014 Predictors of readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Predictors for the rapid decline of FEV1 in chronic obstructive lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 255s Year: 2002 Alternative ways of expressing FEV1 and mortality in elderly people with and without COPD Source: Eur Respir J 2013; 41: 800-805 Year: 2013 Resting heart rate and exacerbations in COPD patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Factors affecting in-hospital mortality in patients with chronic obstructive pulmonary disease exacerbation Source: Annual Congress 2013 –The latest insights in chronic care Year: 2013 Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015 Usefulness of admission red cell distribution Width as a predictor of early mortality in patients with severe exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016